Mortal Kombat 1 celebrates Scorpion with iconic skins referencing past versions, including Hellfire and MK '95. New Era Scorpion, Kuai Liang, sports revamped designs like Eruptive Rage ...

Since its launch in 1992, Mortal Kombat has produced some of the most recognizable fighting game characters ever. These ...

Mortal Kombat achieved notoriety not just for its graphic violence and gore, but for its secrets. Series co-creator Ed Boon has sneaked secret characters — almost always palette-swapped ninjas — into ...

Bringing Joe Taslim's Sub-Zero back as Noob Saibot in the highly-anticipated Mortal Kombat 2 would redeem a mistake the 2021 ...

Ed Boon has provided Mortal Kombat 1 players with their first look at the T-1000 Terminator and its Fatality in a new Twitter post. The fighting game has sold over five million copies to date.

Straight out of Cimmeria, Conan the Barbarian yawps his way into Mortal Kombat 1 later this month as part of the ongoing Khaos Reigns expansion. Conan’s appearance in Mortal Kombat 1 is based ...

Conan The Barbarian joins Mortal Kombat for early access players on January 21, 2025. May Crom help us all. Conan The Barbarian is available with the Khaos Reigns Expansion, Bundle, or Kollection.

Here’s how it works. You can use any of these Fatalities to decimate your rivals locally, or via Mortal Kombat 1 crossplay to expand your pool of opponents. If you picked up the extra pack of ...

The Sukeban female wrestling league made its Miami debut in December, with a championship belt by Marc Newson, hats by Stephen Jones, creative direction by Olympia Le Tan – and a win in the Wallpaper* ...

Eli Lilly has agreed to acquire Scorpion Therapeutics’ breast cancer treatment program for up to $2.5 billion in cash. The drugmaker said Monday it is acquiring Scorpion and its STX-478 program ...

Jan 13 (Reuters) - Eli Lilly (LLY.N), opens new tab said on Monday it plans to buy Scorpion Therapeutics' experimental cancer therapy for up to $2.5 billion in cash to expand its pipeline of ...

SAN FRANCISCO — Eli Lilly said Monday it would acquire a cancer program from startup Scorpion Therapeutics in a deal worth up to $2.5 billion, as the Indianapolis company broadens its pipeline.